Biossimilares ampliam acesso | Abbott Newsroom

Abbott Laboratories · Company update · December 17, 2025

Abbott published an article discussing the role of biosimilar medicines in expanding healthcare access in Brazil, highlighting their cost-effectiveness and safety for treating complex conditions like cancer.

Read the article

AntSpace’s summary of Abbott Laboratories’s own announcement: read the original.

More updates from Abbott Laboratories